Half-yearly performance reports - July to December 2013 (TGA - Therapeutic...
(Source: TGA - Therapeutic Goods Administration) 28 May 2014 The TGA prepares statistical performance reports that are presented biannually to the Therapeutic Goods Industry Consultative...
View ArticleSafety review of diclofenac (TGA - Therapeutic Goods Administration)
(Source: TGA - Therapeutic Goods Administration) Version 2.1, October 2014 7 October 2014 Following the cardiovascular safety review of all NSAIDs and concerns regarding the...
View ArticleReview of cardiovascular safety of non-steroidal anti-inflammatory drugs (TGA...
(Source: TGA - Therapeutic Goods Administration) Version 2.1, October 2014 7 October 2014 A review has been carried out of the relevant medical literature published since 2005 and other relevant data...
View ArticleTGA key performance indicators: January to June 2014 (TGA - Therapeutic Goods...
(Source: TGA - Therapeutic Goods Administration) Version 1.0, August 2014 Version history Version Description of change Author Effective date V1.0 Original publication TGA August 2014 TGA key...
View ArticleRegulation impact statement: Premarket assessment requirements for Australian...
(Source: TGA - Therapeutic Goods Administration) 15 October 2014 This Regulation Impact Statement (RIS) has been prepared by the Therapeutic Goods Administration (TGA). The purpose is to assist...
View ArticleRequired advisory statements for medicine labels (RASML) (TGA - Therapeutic...
9 November 2012 The RASML document is a compilation of all mandatory medicine label advisory statements, including those from the Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) and...
View ArticleDocuments released under Section 11C of the Freedom of Information Act 1982...
(Source: TGA - Therapeutic Goods Administration) Related information *Large file warning:Attempting to open large files over the Internet within the browser window may cause problems. It is strongly...
View ArticleInaccuracies in clinical trial statistics reporting for the period 2009-2012...
(Source: TGA - Therapeutic Goods Administration) 1 August 2013 The Therapeutic Goods Administration (TGA) has identified errors in its internal reports of clinical trial numbers for the period 1 July...
View ArticleConsultation: Draft OTC medicine monograph for guaifenesin (TGA - Therapeutic...
(Source: TGA - Therapeutic Goods Administration) 12 September 2014 Closing date: 10 October 2014 Invitation to comment The TGA is seeking comments from interested parties on the draft OTC medicine...
View ArticleConsultation: Draft OTC medicine monograph for mebendazole (TGA - Therapeutic...
(Source: TGA - Therapeutic Goods Administration) 12 September 2014 Closing date: 10 October 2014 Invitation to comment The TGA is seeking comments from interested parties on the draft OTC medicine...
View ArticleConsultation: Draft OTC medicine monograph for ranitidine hydrochloride (TGA...
(Source: TGA - Therapeutic Goods Administration) 12 September 2014 Closing date: 10 October 2014 Invitation to comment The TGA is seeking comments from interested parties on the draft OTC medicine...
View ArticleConsultation: Draft OTC medicine monograph for loperamide hydrochloride (TGA...
(Source: TGA - Therapeutic Goods Administration) 12 September 2014 Closing date: 10 October 2014 Invitation to comment The TGA is seeking comments from interested parties on the draft OTC medicine...
View ArticleConsultation: Medicine labelling (TGA - Therapeutic Goods Administration)
(Source: TGA - Therapeutic Goods Administration) 22 August 2014 Closing date: 7 October 2014 Invitation to comment The TGA is seeking comments from interested parties on any, or all, of the proposed...
View ArticleConsultation: Permitted (coded) indications for listed medicines (TGA -...
(Source: TGA - Therapeutic Goods Administration) 14 January 2013 Closing date: Friday 15 March 2013 Consultation documents Consultation: Permitted (coded) indications for listed medicines Consultation:...
View ArticleConsultation: Changes to premarket assessment requirements for medical...
(Source: TGA - Therapeutic Goods Administration) Closing date: Friday 15 March 2013 Consultation documents * Changes to premarket assessment requirements for medical devices: Proposal paper (Microsoft...
View ArticleConsultation principles for therapeutic goods regulatory reforms (TGA -...
(Source: TGA - Therapeutic Goods Administration) Your browser appears to have JavaScript disabled. The TGA mobile website works best with JavaScript enabled. 21 June 2013 We have...
View ArticleConsultation: Review of cardiovascular safety of non-steroidal...
(Source: TGA - Therapeutic Goods Administration) 7 October 2014 Closing date: 6 November 2014 Invitation to comment The TGA is seeking comments from interested parties following a Review of...
View ArticleConsultation: Loratadine and desloratadine: proposed advisory statements for...
Version 1.0 9 November 2012 Closing date: 7 December 2012 Invitation to comment The TGA is seeking comments from interested parties on the proposed advisory statement for loratadine and desloratadine...
View ArticleAustralian Therapeutic Goods Advisory Council (TGA - Therapeutic Goods...
(Source: TGA - Therapeutic Goods Administration) 16 January 2013 Introduction On 16 July 2012, the Australian Government announced that it would establish an Australian Therapeutic Goods Advisory...
View ArticleTGA reforms: A blueprint for TGA's future: Progress report as at 30 June 2014...
(Source: TGA - Therapeutic Goods Administration) 25 September 2014 TGA reforms: A blueprint for TGA's future - Progress report as at 30 June 2014 is the fourth six monthly progress report on reforms...
View Article
